Rocket Lab Corp 8-K, filed Nov 9, 2026
Rocket Lab Corp (RKLB)
8-K
2026-11-09
For: 2026-11-09
View Original
Added on
November 09, 2026
About this 8-K
Rocket Lab Corp filed this 8-K on November 9, 2026.
Rocket Lab reported third-quarter 2026 revenue of $268 million, up 73% year-on-year, and approximately $3.6 billion backlog, up 52% since the end of the second quarter. Fourth-quarter 2026 revenue is guided at $270 million to $290 million. AI summary
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 9, 2026
(Exact name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
Registrant’s Telephone Number, Including Area Code: 714 465-5737
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 9, 2026, Rocket Lab Corporation (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 (the “Section”) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ROCKET LAB CORPORATION | |||||||||||
| Date: | November 9, 2026 | By: | /s/ Adam Spice | ||||||||
| Adam Spice Chief Financial Officer | |||||||||||
MEDIA RELEASE |  | ||||
Exhibit 99.1
Rocket Lab Announces Third Quarter 2026 Financial Results: Posts Record Revenue, $1.2 Billion or 52% Sequential Quarterly Backlog Growth, Positive GAAP Operating Cash Flow, and Guides to Record Revenue and Gross Margin Expansion in Q4 2026
Long Beach, California. November 9, 2026 – Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter ended September 30, 2026.
Rocket Lab founder and CEO, Sir Peter Beck, says: “Q3 2026 was a defining quarter for Rocket Lab. We delivered a record $268 million in revenue ($34 million higher than Q2 2026) alongside a record backlog which has grown to $3.57 billion. Nearly $1 billion of that backlog comes from new launch contracts, signed in Q3 2026 alone, as well as $470 million signed for Space Systems. Our end-to-end space strategy is delivering exactly as designed: the world's most critical and ambitious missions increasingly rely on Rocket Lab for launch, spacecraft, and components, sometimes all on a single mission, and every part of our business is growing as a result.”
Highlights for the Third Quarter 2026, plus business updates since September 30, 2026.
•Record quarterly revenue of $268 million, a 73% increase year-on-year.
•Record backlog of approximately $3.6 billion, a 52% increase since end of Q2 2026.
•Positive GAAP operating cash flow of $7.2M.
•Approximately $1 billion in new launch contracts signed across Electron, HASTE, and Neutron, bringing Rocket Lab’s total launch backlog to 117 launches: a new record.
•Secured over $515M in Neutron launch contracts from constellation operators in Q3, growing the rocket’s backlog to 16 missions ahead of its debut and lifting the base launch price to $70 million for several of these missions as industry launch capacity tightens. With first launch now targeted for no earlier than 2027, critical milestones continue to be achieved across assembly, integration, testing, and delivery of first flight hardware to Launch Complex 3.
•Twelve Rocket Lab-built spacecraft successfully launched to orbit and now operating, including eight satellite platforms for Globalstar’s direct-to-device communications constellation, twin spacecraft conducting Mars science for NASA, the responsive space VICTUS HAZE mission for the United States Space Force, and a single spacecraft for Viasat’s NASA Communications Services Depot.
•More than 55 spacecraft now in development and build across Rocket Lab’s production complexes, including spacecraft for NASA, the Space Development Agency, USSF, and commercial constellation operators.
•Fully funded Rocket Lab’s pending acquisition of Iridium Communications through a completed ATM equity offering and received approval by Iridium lenders to maintain Iridium’s credit facility post-transaction, and obtained overwhelming approval from Iridium shareholders in favor of the acquisition.
rocketlabcorp.com | media@rocketlabusa.com
MEDIA RELEASE | | ||||
Fourth Quarter 2026 Guidance
For the fourth quarter of 2026, Rocket Lab expects:
•Revenue between $270 million and $290 million.
•GAAP Gross Margins between 34% and 36%.
•Non-GAAP Gross Margins between 39% and 41%.
•GAAP Operating Expenses between $162 million and $168 million.
•Non-GAAP Operating Expenses between $136 million and $142 million.
•Interest Income net $45 million.
•Adjusted EBITDA loss of between $14 million and $20 million.
•Basic Weighted Average Common Shares Outstanding of 681 million, including approximately 41 million of Series A Convertible Participating Preferred Shares.
See “Use of Non-GAAP Financial Measures” below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q4 2026 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $17 million to $19 million in Q4 2026.
Conference Call Information
Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our third quarter, other updates, and to provide our outlook for the fourth quarter 2026.
The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabcorp.com/
Rocket Lab Investor Relations Contact
Patrick Vorenkamp
investors@rocketlabusa.com
Rocket Lab Media Contact
Murielle Baker
media@rocketlabusa.com
About Rocket Lab
Rocket Lab (Nasdaq: RKLB) is an end-to-end space company delivering rockets, satellites, and spacecraft components for commercial, government, and defense missions. Driven by its industry-leading small-lift rockets Electron and HASTE and its upcoming reusable Neutron medium-lift rocket, Rocket Lab delivers reliable and responsive launch for the world’s most important missions from constellation deployment to missile defense. Rocket Lab’s satellites and components have powered more than 1,700 missions in Earth orbit, as well as deep-space exploration of the Moon, Mars, and beyond. Learn more at www.rocketlabcorp.com.
rocketlabcorp.com | media@rocketlabusa.com
MEDIA RELEASE | | ||||
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the fourth quarter of 2026, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development and anticipated timeline to launch, operational expansion, business strategy, our backlog, revenue momentum, and contract activity; and the anticipated benefits or impacts of our pending acquisition of Iridium Communications are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.investors.rocketlabcorp.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Use of Non-GAAP Financial Measures
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (“GAAP”) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:
Adjusted EBITDA
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.
rocketlabcorp.com | media@rocketlabusa.com
MEDIA RELEASE | | ||||
Other Non-GAAP Financial Measures
Non-GAAP gross profit, gross margin, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.
rocketlabcorp.com | media@rocketlabusa.com
| MEDIA RELEASE | | ||||
ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(unaudited; in thousands, except share and per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenues: | |||||||||||||||||||||||
| Product revenues | $ | 197,487 | $ | 104,042 | $ | 506,322 | $ | 277,571 | |||||||||||||||
| Service revenues | 70,347 | 51,038 | 195,926 | 144,576 | |||||||||||||||||||
| Total revenues | 267,834 | 155,080 | 702,248 | 422,147 | |||||||||||||||||||
| Cost of revenues: | |||||||||||||||||||||||
| Cost of product revenues | 133,077 | 72,841 | 331,600 | 188,402 | |||||||||||||||||||
| Cost of service revenues | 44,686 | 24,925 | 119,508 | 94,796 | |||||||||||||||||||
| Total cost of revenues | 177,763 | 97,766 | 451,108 | 283,198 | |||||||||||||||||||
| Gross profit | 90,071 | 57,314 | 251,140 | 138,949 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development, net | 98,388 | 70,694 | 261,330 | 191,937 | |||||||||||||||||||
| Selling, general and administrative | 70,872 | 45,589 | 182,482 | 124,808 | |||||||||||||||||||
| Total operating expenses | 169,260 | 116,283 | 443,812 | 316,745 | |||||||||||||||||||
| Operating loss | (79,189) | (58,969) | (192,672) | (177,796) | |||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||
| Interest expense | (323) | (7,285) | (2,178) | (21,470) | |||||||||||||||||||
| Interest income | 28,627 | 6,695 | 55,262 | 15,923 | |||||||||||||||||||
| Gain (loss) on foreign exchange | 473 | 388 | (1,325) | (235) | |||||||||||||||||||
| Loss on extinguishment of debt | (27,259) | — | (27,259) | — | |||||||||||||||||||
| Other income (expense), net | 1,497 | (177) | 1,253 | (675) | |||||||||||||||||||
| Total other income (expense), net | 3,015 | (379) | 25,753 | (6,457) | |||||||||||||||||||
| Loss before income taxes | (76,174) | (59,348) | (166,919) | (184,253) | |||||||||||||||||||
| (Provision) benefit for income taxes | (3,503) | 41,091 | (7,038) | 38,966 | |||||||||||||||||||
| Net loss | $ | (79,677) | $ | (18,257) | $ | (173,957) | $ | (145,287) | |||||||||||||||
| Net loss per share attributable to Rocket Lab Corporation: | |||||||||||||||||||||||
| Basic and diluted | $ | (0.12) | $ | (0.03) | $ | (0.28) | $ | (0.28) | |||||||||||||||
| Weighted-average common shares outstanding: | |||||||||||||||||||||||
| Basic and diluted | 652,263,684 | 528,725,980 | 629,298,251 | 516,560,266 | |||||||||||||||||||
rocketlabcorp.com | media@rocketlabusa.com
| MEDIA RELEASE | | ||||
ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2026 AND DECEMBER 31, 2025
(unaudited; in thousands, except share and per share values)
| September 30, 2026 | December 31, 2025 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 4,447,665 | $ | 828,660 | |||||||
| Marketable securities, current | 160,290 | 187,917 | |||||||||
| Accounts receivable, net | 118,311 | 39,001 | |||||||||
| Contract assets | 124,361 | 61,606 | |||||||||
| Inventories | 280,885 | 158,407 | |||||||||
| Prepaids and other current assets | 121,413 | 89,953 | |||||||||
| Total current assets | 5,252,925 | 1,365,544 | |||||||||
| Non-current assets: | |||||||||||
| Property, plant and equipment, net | 410,083 | 319,473 | |||||||||
| Intangible assets, net | 307,849 | 224,746 | |||||||||
| Goodwill | 301,420 | 205,750 | |||||||||
| Right-of-use assets - operating leases | 112,449 | 90,371 | |||||||||
| Right-of-use assets - finance leases | 12,155 | 13,895 | |||||||||
| Marketable securities, non-current | 95,894 | 82,247 | |||||||||
| Restricted cash | 8,414 | 4,885 | |||||||||
| Deferred income tax assets, net | 2,009 | 1,895 | |||||||||
| Other non-current assets | 65,509 | 15,672 | |||||||||
| Total assets | $ | 6,568,707 | $ | 2,324,478 | |||||||
| Liabilities and Stockholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Trade payables | $ | 85,150 | $ | 72,699 | |||||||
| Accrued expenses | 19,285 | 19,299 | |||||||||
| Employee benefits payable | 45,068 | 25,803 | |||||||||
| Contract liabilities | 423,580 | 195,438 | |||||||||
| Other current liabilities | 41,035 | 21,237 | |||||||||
| Total current liabilities | 614,118 | 334,476 | |||||||||
| Non-current liabilities: | |||||||||||
| Convertible senior notes, net | 1,289 | 152,395 | |||||||||
| Long-term borrowings, net | 1,716 | 1,716 | |||||||||
| Non-current operating lease liabilities | 102,905 | 85,191 | |||||||||
| Non-current finance lease liabilities | 14,374 | 14,653 | |||||||||
| Deferred income tax liabilities | 10,399 | 1,241 | |||||||||
| Other non-current liabilities | 21,336 | 12,952 | |||||||||
| Total liabilities | 766,137 | 602,624 | |||||||||
| COMMITMENTS AND CONTINGENCIES | |||||||||||
| Stockholders’ equity: | |||||||||||
| Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 40,951,250 and 45,951,250 at September 30, 2026 and December 31, 2025, respectively | 4 | 5 | |||||||||
| Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 680,114,963 and 589,525,802 at September 30, 2026 and December 31, 2025, respectively; outstanding shares: 639,163,713 and 543,574,552 at September 30, 2026 and December 31, 2025, respectively | 64 | 54 | |||||||||
| Treasury stock, at cost; shares: 40,951,250 and 45,951,250 at September 30, 2026 and December 31, 2025, respectively | — | — | |||||||||
| Additional paid-in capital | 6,998,701 | 2,735,669 | |||||||||
| Accumulated deficit | (1,185,867) | (1,011,910) | |||||||||
| Accumulated other comprehensive loss | (10,332) | (1,964) | |||||||||
| Total stockholders’ equity | 5,802,570 | 1,721,854 | |||||||||
| Total liabilities and stockholders’ equity | $ | 6,568,707 | $ | 2,324,478 | |||||||
rocketlabcorp.com | media@rocketlabusa.com
| MEDIA RELEASE | | ||||
ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(unaudited; in thousands)
| For the Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net loss | $ | (173,957) | $ | (145,287) | |||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
| Depreciation and amortization | 57,651 | 29,191 | |||||||||
| Stock-based compensation expense | 66,001 | 52,894 | |||||||||
| (Gain) loss on disposal of assets | (369) | 2,356 | |||||||||
| Loss on equity securities | 882 | — | |||||||||
| Loss on extinguishment of debt | 27,259 | — | |||||||||
| Lower of cost or market inventory valuation adjustments | 7,462 | — | |||||||||
| Amortization of inventory step-up | 399 | — | |||||||||
| Amortization of debt issuance costs and discount | 189 | 2,551 | |||||||||
| Noncash lease expense | 9,863 | 5,975 | |||||||||
| Change in the fair value of contingent consideration | (2,058) | — | |||||||||
| Accretion of marketable securities purchased at a discount | (1,278) | (1,599) | |||||||||
| Deferred income taxes | 514 | (33,049) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable, net | (68,468) | (19,442) | |||||||||
| Contract assets | (60,769) | 12,608 | |||||||||
| Inventories | (83,731) | (25,567) | |||||||||
| Prepaids and other current assets | (20,501) | (17,455) | |||||||||
| Other non-current assets | (48,622) | 10,132 | |||||||||
| Trade payables | 6,892 | (1,634) | |||||||||
| Accrued expenses | (280) | 2,671 | |||||||||
| Employee benefits payable | 11,875 | 43,417 | |||||||||
| Contract liabilities | 144,485 | (9,187) | |||||||||
| Other current liabilities | 9,859 | (1,358) | |||||||||
| Non-current lease liabilities | (10,775) | (8,269) | |||||||||
| Other non-current liabilities | 223 | 62 | |||||||||
| Net cash used in operating activities | (127,254) | (100,990) | |||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||
| Purchases of property, equipment and software | (84,185) | (106,631) | |||||||||
| Proceeds on disposal of assets | 715 | 397 | |||||||||
| Cash paid for business combinations, net of acquired cash | (44,271) | (132,441) | |||||||||
| Purchases of marketable securities | (221,667) | (187,780) | |||||||||
| Maturities of marketable securities | 235,515 | 179,822 | |||||||||
| Sale of marketable securities | — | 3,383 | |||||||||
| Net cash used in investing activities | (113,893) | (243,250) | |||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
Proceeds from ATM Equity Offerings | 3,911,859 | 865,453 | |||||||||
| Issuance costs related to ATM Equity Offerings | (36,695) | (20,134) | |||||||||
| Proceeds from the exercise of stock options | 1,778 | 2,539 | |||||||||
| Proceeds from Employee Stock Purchase Plan | 13,605 | 7,751 | |||||||||
| Proceeds from sale of employees’ restricted stock units to cover taxes | 190,665 | 80,659 | |||||||||
| Minimum tax withholding paid on behalf of employees for restricted stock units | (189,835) | (65,672) | |||||||||
Proceeds from secured term loans | — | 26,716 | |||||||||
| Repayments on secured term loan | — | (15,103) | |||||||||
| Payment of debt issuance and extinguishment costs | (27,259) | (278) | |||||||||
| Finance lease principal payments | (232) | (197) | |||||||||
| Net cash provided by financing activities | 3,863,886 | 881,734 | |||||||||
| Effect of exchange rate changes on cash and cash equivalents | (205) | (86) | |||||||||
| Net increase in cash and cash equivalents and restricted cash | 3,622,534 | 537,408 | |||||||||
| Cash and cash equivalents, and restricted cash, beginning of period | 833,545 | 275,302 | |||||||||
| Cash and cash equivalents, and restricted cash, end of period | $ | 4,456,079 | $ | 812,710 | |||||||
rocketlabcorp.com | media@rocketlabusa.com
| MEDIA RELEASE | | ||||
ROCKET LAB CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(unaudited; in thousands)
The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| NET LOSS | $ | (79,677) | $ | (18,257) | $ | (173,957) | $ | (145,287) | |||||||||||||||
| Depreciation | 9,550 | 6,490 | 27,236 | 18,061 | |||||||||||||||||||
| Amortization | 12,168 | 5,236 | 30,415 | 11,130 | |||||||||||||||||||
| Stock-based compensation expense | 18,324 | 15,727 | 66,001 | 52,894 | |||||||||||||||||||
| Transaction costs | 21,340 | 5,118 | 31,584 | 11,504 | |||||||||||||||||||
| Interest expense | 323 | 7,285 | 2,178 | 21,470 | |||||||||||||||||||
| Interest income | (28,627) | (6,695) | (55,262) | (15,923) | |||||||||||||||||||
| Change in fair value of contingent consideration | (2,444) | — | (2,058) | — | |||||||||||||||||||
| Amortization of inventory step-up | 216 | — | 399 | — | |||||||||||||||||||
| Provision (benefit) for income taxes | 3,503 | (41,091) | 7,038 | (38,966) | |||||||||||||||||||
| (Gain) loss on foreign exchange | (473) | (388) | 1,325 | 235 | |||||||||||||||||||
| Loss on equity securities | 882 | — | 882 | — | |||||||||||||||||||
| Accretion of marketable securities and cash equivalents purchased at a discount | (425) | (553) | (1,302) | (1,810) | |||||||||||||||||||
| Loss (gain) on disposal of assets | 34 | 853 | (369) | 2,356 | |||||||||||||||||||
| Employee retention credit | — | — | — | 515 | |||||||||||||||||||
| Loss on extinguishment of debt | 27,259 | — | 27,259 | — | |||||||||||||||||||
| ADJUSTED EBITDA | $ | (18,047) | $ | (26,275) | $ | (38,631) | $ | (83,821) | |||||||||||||||
rocketlabcorp.com | media@rocketlabusa.com
| MEDIA RELEASE | | ||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| GAAP Gross profit | $ | 90,071 | $ | 57,314 | $ | 251,140 | $ | 138,949 | |||||||||||||||
| Stock-based compensation | 4,773 | 3,539 | 13,369 | 12,351 | |||||||||||||||||||
| Amortization of purchased intangibles and favorable lease | 7,692 | 4,126 | 20,970 | 7,772 | |||||||||||||||||||
| Amortization of inventory step-up | 216 | — | 399 | — | |||||||||||||||||||
| Employee retention credit | — | — | — | 278 | |||||||||||||||||||
| Non-GAAP Gross profit | $ | 102,752 | $ | 64,979 | $ | 285,878 | $ | 159,350 | |||||||||||||||
| Non-GAAP Gross margin | 38.4 | % | 41.9 | % | 40.7 | % | 37.7 | % | |||||||||||||||
| GAAP Research and development, net | $ | 98,388 | $ | 70,694 | $ | 261,330 | $ | 191,937 | |||||||||||||||
| Stock-based compensation | (5,645) | (5,588) | (18,425) | (16,055) | |||||||||||||||||||
| Amortization of purchased intangibles and favorable lease | — | — | — | (329) | |||||||||||||||||||
| Employee retention credit | — | — | — | (88) | |||||||||||||||||||
| Non-GAAP Research and development, net | $ | 92,743 | $ | 65,106 | $ | 242,905 | $ | 175,465 | |||||||||||||||
| GAAP Selling, general and administrative | $ | 70,872 | $ | 45,589 | $ | 182,482 | $ | 124,808 | |||||||||||||||
| Stock-based compensation | (7,906) | (6,600) | (34,207) | (24,488) | |||||||||||||||||||
| Amortization of purchased intangibles and favorable lease | (4,192) | (846) | (8,599) | (2,250) | |||||||||||||||||||
| Transaction costs | (21,340) | (5,118) | (31,584) | (11,504) | |||||||||||||||||||
| Employee retention credit | — | — | — | (149) | |||||||||||||||||||
| Non-GAAP Selling, general and administrative | $ | 37,434 | $ | 33,025 | $ | 108,092 | $ | 86,417 | |||||||||||||||
| GAAP Operating expenses | $ | 169,260 | $ | 116,283 | $ | 443,812 | $ | 316,745 | |||||||||||||||
| Stock-based compensation | (13,551) | (12,188) | (52,632) | (40,543) | |||||||||||||||||||
| Amortization of purchased intangibles and favorable lease | (4,192) | (846) | (8,599) | (2,579) | |||||||||||||||||||
| Transaction costs | (21,340) | (5,118) | (31,584) | (11,504) | |||||||||||||||||||
| Employee retention credit | — | — | — | (237) | |||||||||||||||||||
| Non-GAAP Operating expenses | $ | 130,177 | $ | 98,131 | $ | 350,997 | $ | 261,882 | |||||||||||||||
| GAAP Operating loss | $ | (79,189) | $ | (58,969) | $ | (192,672) | $ | (177,796) | |||||||||||||||
| Total non-GAAP adjustments | 51,764 | 25,817 | 127,553 | 75,264 | |||||||||||||||||||
| Non-GAAP Operating loss | $ | (27,425) | $ | (33,152) | $ | (65,119) | $ | (102,532) | |||||||||||||||
| GAAP Total other income (expense), net | $ | 3,015 | $ | (379) | $ | 25,753 | $ | (6,457) | |||||||||||||||
| (Gain) loss on foreign exchange | (473) | (388) | 1,325 | 235 | |||||||||||||||||||
| Loss on equity securities | 882 | — | 882 | — | |||||||||||||||||||
| Loss (gain) on disposal of assets | 34 | 853 | (369) | 2,356 | |||||||||||||||||||
| Loss on extinguishment of debt | 27,259 | — | 27,259 | — | |||||||||||||||||||
| Change in fair value of contingent consideration | (2,444) | — | (2,058) | — | |||||||||||||||||||
| Non-GAAP Total other income (expense), net | $ | 28,273 | $ | 86 | $ | 52,792 | $ | (3,866) | |||||||||||||||
rocketlabcorp.com | media@rocketlabusa.com